Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Imatinib mesilate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Imatinib 100mg tablets
0801050AAAAACAC
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 8 |
|
Imatinib 100mg capsules
0801050AAAAAAAA
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 3 |
|
Imatinib 400mg capsules
0801050AAAAADAD
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 2 |
|
Imatinib 400mg tablets
0801050AAAAABAB
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 2 |
|
Glivec 100mg capsules
0801050AABBAAAA
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Glivec 100mg tablets
0801050AABBACAC
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Glivec 400mg tablets
0801050AABBABAB
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Nibix 100mg capsules
0801050AABCAAAA
|
Nibix | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Nibix 400mg capsules
0801050AABCABAD
|
Nibix | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.